Clinical Management of Ocular Surface Disease

A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Ophthalmology".

Deadline for manuscript submissions: 25 May 2024 | Viewed by 622

Special Issue Editors


E-Mail Website
Guest Editor
Department of Clinical, Pharmaceutical and Biological Science, School of Life and Medical Sciences, University of Hertfordshire, Hatfield, UK
Interests: optometry; dry eye; cornea; ocular nutrition, contact lenses; intraocular lenses

E-Mail Website
Guest Editor
1. Ocular Surface Laboratory, Department of Ophthalmology, New Zealand National Eye Centre, The University of Auckland, Auckland, New Zealand
2. Optometry and Vision Sciences Research Group, Aston University, Birmingham, UK
3. Centre for Ocular Research and Education, University of Waterloo, Waterloo, ON, Canada
Interests: dry eye disease; ocular surface disease; meibomian gland dysfunction; tear film; contact lenses; microbial keratitis; refractive surgery
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Ocular surface health is important in maintaining normal vision and may be affected by several disease processes including dry eye disease, which is now one of the most prevalent ophthalmic conditions globally. Its growth has been driven by factors including the rapid increase in the use of electronic devices and an ageing population.

Medical management of ocular surface diseases can help to reduce inflammation, resolve infection, improve the tear film, and alleviate patient symptoms. Treatment options include topical and systemic medications, light therapies, and lifestyle adjustments. Ocular surface diseases are often multifactorial and thus require a multifaceted treatment approach. The development of long-lasting therapies is vital for the effective management of the chronic ocular surface diseases.

The objective of this Special Issue on ‘Clinical Management of Ocular Surface Disease’ is to summarize the frequently encountered ocular surface diseases and the latest developments in their diagnosis and treatment as well as emerging management options.

Dr. Sandeep K. Dhallu
Prof. Dr. Jennifer P. Craig
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • ocular surface disease
  • demodex infestation
  • blepharitis
  • meibomian gland dysfunction
  • allergic conjunctivitis
  • dry eye disease
  • epithelial basement membrane dystrophy
  • Salzmann’s nodular degeneration
 

Published Papers

This special issue is now open for submission.
Back to TopTop